Angelo Maiolino, MD, PhD
Angelo Maiolino, MD, PhD
Verified email at
Cited by
Cited by
Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: a multicenter international myeloma working group study
SK Kumar, JH Lee, JJ Lahuerta, G Morgan, PG Richardson, J Crowley, ...
Leukemia 26 (1), 149-157, 2012
Fusarium Infection in Hematopoietic Stem Cell Transplant Recipients
M Nucci, KA Marr, F Queiroz-Telles, CA Martins, P Trabasso, S Costa, ...
Clinical Infectious Diseases 38 (9), 1237-1242, 2004
Outcome predictors of 84 patients with hematologic malignancies and Fusarium infection
M Nucci, EJ Anaissie, F Queiroz‐Telles, CA Martins, P Trabasso, C Solza, ...
Cancer 98 (2), 315-319, 2003
Isatuximab, carfilzomib, and dexamethasone in relapsed multiple myeloma (IKEMA): a multicentre, open-label, randomised phase 3 trial
P Moreau, MA Dimopoulos, J Mikhael, K Yong, M Capra, T Facon, ...
The Lancet 397 (10292), 2361-2371, 2021
Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial
MA Dimopoulos, F Gay, F Schjesvold, M Beksac, R Hajek, KC Weisel, ...
The Lancet 393 (10168), 253-264, 2019
Epidemiology of bacteremia and factors associated with multi-drug-resistant gram-negative bacteremia in hematopoietic stem cell transplant recipients
AL Oliveira, M De Souza, VMH Carvalho-Dias, MA Ruiz, L Silla, ...
Bone marrow transplantation 39 (12), 775-781, 2007
Engraftment syndrome following autologous hematopoietic stem cell transplantation: definition of diagnostic criteria
A Maiolino, I Biasoli, J Lima, AC Portugal, W Pulcheri, M Nucci
Bone marrow transplantation 31 (5), 393-397, 2003
Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group
P Moreau, SK Kumar, J San Miguel, F Davies, E Zamagni, N Bahlis, ...
The Lancet Oncology 22 (3), e105-e118, 2021
Analysis of the immune system of multiple myeloma patients achieving long-term disease control by multidimensional flow cytometry
RJP de Magalhães, MB Vidriales, B Paiva, C Fernandez-Gimenez, ...
Haematologica 98 (1), 79, 2013
Migration and homing of bone-marrow mononuclear cells in chronic ischemic stroke after intra-arterial injection
LMB da Fonseca, B Gutfilen, PHR de Castro, V Battistella, ...
Experimental neurology 221 (1), 122-128, 2010
A phase 2, randomized, double‐blind, placebo‐controlled study of siltuximab (anti‐IL‐6 mAb) and bortezomib versus bortezomib alone in patients with relapsed or refractory …
RZ Orlowski, L Gercheva, C Williams, H Sutherland, T Robak, T Masszi, ...
American journal of hematology 90 (1), 42-49, 2015
High response rate to bortezomib with or without dexamethasone in patients with relapsed or refractory multiple myeloma: results of a global phase 3b expanded access program
JR Mikhael, AR Belch, HM Prince, MN Lucio, A Maiolino, A Corso, ...
British journal of haematology 144 (2), 169-175, 2009
Biodistribution of bone marrow mononuclear cells after intra-arterial or intravenous transplantation in subacute stroke patients
PH Rosado-de-Castro, FR Schmidt, V Battistella, SA Lopes de Souza, ...
Regenerative medicine 8 (2), 145-155, 2013
Salvage second hematopoietic cell transplantation in myeloma
LC Michaelis, A Saad, X Zhong, J Le-Rademacher, CO Freytes, DI Marks, ...
Biology of Blood and Marrow Transplantation 19 (5), 760-766, 2013
Serum ferritin as risk factor for sinusoidal obstruction syndrome of the liver in patients undergoing hematopoietic stem cell transplantation
SC Maradei, A Maiolino, AM de Azevedo, M Colares, LF Bouzas, M Nucci
Blood, The Journal of the American Society of Hematology 114 (6), 1270-1275, 2009
Trends in allogeneic stem cell transplantation for multiple myeloma: a CIBMTR analysis
S Kumar, MJ Zhang, P Li, A Dispenzieri, GA Milone, S Lonial, A Krishnan, ...
Blood, The Journal of the American Society of Hematology 118 (7), 1979-1988, 2011
International harmonization in performing and reporting minimal residual disease assessment in multiple myeloma trials
LJ Costa, BA Derman, S Bal, S Sidana, S Chhabra, R Silbermann, JC Ye, ...
Leukemia 35 (1), 18-30, 2021
Blood monitoring of circulating tumor plasma cells by next generation flow in multiple myeloma after therapy
L Sanoja-Flores, J Flores-Montero, N Puig, T Contreras-Sanfeliciano, ...
Blood, The Journal of the American Society of Hematology 134 (24), 2218-2222, 2019
Older patients with myeloma derive similar benefit from autologous transplantation
M Sharma, MJ Zhang, X Zhong, MH Abidi, G Akpek, U Bacher, ...
Biology of Blood and Marrow Transplantation 20 (11), 1796-1803, 2014
Bone marrow mononuclear cell therapy for patients with cirrhosis: a Phase 1 study
BG Couto, RCS Goldenberg, LMB da Fonseca, J Thomas, B Gutfilen, ...
Liver International 31 (3), 391-400, 2011
The system can't perform the operation now. Try again later.
Articles 1–20